KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Tax ProvisionsTax Rate
Others
Ratios

BioNTech SE (BNTX) Interest & Investment Income (2018 - 2025)

Historic Interest & Investment Income for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $113.2 million.

  • BioNTech SE's Interest & Investment Income fell 3403.1% to $113.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $538.0 million, marking a year-over-year decrease of 2552.12%. This contributed to the annual value of $709.5 million for FY2024, which is 2691.83% up from last year.
  • Latest data reveals that BioNTech SE reported Interest & Investment Income of $113.2 million as of Q3 2025, which was down 3403.1% from $119.3 million recorded in Q2 2025.
  • BioNTech SE's 5-year Interest & Investment Income high stood at $305.4 million for Q1 2022, and its period low was $361281.4 during Q2 2021.
  • In the last 5 years, BioNTech SE's Interest & Investment Income had a median value of $123.2 million in 2022 and averaged $120.8 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first skyrocketed by 312788546654.7% in 2021, then plummeted by 7107.42% in 2023.
  • Over the past 5 years, BioNTech SE's Interest & Investment Income (Quarter) stood at $18.6 million in 2021, then surged by 112.29% to $39.6 million in 2022, then surged by 340.86% to $174.5 million in 2023, then rose by 1.15% to $176.5 million in 2024, then tumbled by 35.9% to $113.2 million in 2025.
  • Its Interest & Investment Income was $113.2 million in Q3 2025, compared to $119.3 million in Q2 2025 and $129.0 million in Q1 2025.